4//SEC Filing
Atkinson James G. 4
Accession 0001437749-19-002143
CIK 0000879682other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 3:52 PM ET
Size
7.6 KB
Accession
0001437749-19-002143
Insider Transaction Report
Form 4
Atkinson James G.
CBO & President
Transactions
- Award
Common Stock
2019-01-29+42,420→ 53,945 total
Holdings
- 621,237(indirect: By IRA)
Common Stock
- 285,599(indirect: By Trust)
Common Stock
- 3,825(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received a restricted stock award of 42,420 shares of common stock on January 29, 2019 (the "Grant Date"). The restricted stock award shall vest in full upon the FDA approval of the Viveve System for improvement of sexual function or stress urinary incontinence (SUI) in the United States.
- [F2]Shares directly beneficially owned by an individual retirement account created for the benefit of the reporting person (the "IRA"). The reporting person is the beneficiary of the IRA.
- [F3]Shares directly beneficially owned by Atkinson Family Revocable Trust Dated 08/26/2013 (the "Trust"). The reporting person a trustee and a co-beneficiary of the Trust.
- [F4]Shares purchased pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as custodian for a minor child.
Documents
Issuer
VIVEVE MEDICAL, INC.
CIK 0000879682
Entity typeother
Related Parties
1- filerCIK 0001633167
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 3:52 PM ET
- Size
- 7.6 KB